Steven O'Day - 14 Nov 2024 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Chief Medical Officer
Signature
/s/Christine Klaskin, as attorney-in-fact for Steven O'Day
Issuer symbol
AGEN
Transactions as of
14 Nov 2024
Net transactions value
$0
Form type
4
Filing time
18 Nov 2024, 16:05:03 UTC
Previous filing
18 Jun 2024
Next filing
30 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGEN Stock Option Award $0 +50,000 $0.000000 50,000 14 Nov 2024 Common Stock 50,000 $2.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a one-time retention award comprised of options to purchase common stock, which were granted to certain key employees, including our executive officers. These options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan and will vest on November 15, 2025.